Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Psychosom Med. 2010 Oct 14;73(1):2–6. doi: 10.1097/PSY.0b013e3181fdfb25

Table 2.

Logistic Regression Models Predicting ET-1 Risk Elevation

Variable Point Estimate 95% Wald Confidence Limits P-Value
Model 1
BDI Score - Continuous 1.14 1.05 1.24 0.002

Model 2
BDI1 Score - Continuous 1.15 1.05 1.25 0.002
Use of Beta-Blockers 0.51 0.15 1.71 0.28
Diabetes 0.80 0.28 2.31 0.68
Age 1.04 0.98 1.10 0.18
Use of Statins 0.77 0.13 4.45 0.70
Hypertension 0.44 0.12 1.67 0.77

Model 3
BDI1 Score ≥ 10 3.55 1.42 8.87 0.007

Model 4
BDI1 Score ≥ 10 3.89 1.47 10.31 0.007
Use of Beta-Blockers 0.65 0.20 2.07 0.46
Diabetes 0.86 0.30 2.45 0.77
Age 1.04 0.98 1.09 0.21
Use of Statins 0.79 0.14 4.48 0.79
Hypertension 3.87 0.67 22.23 0.13

ET-1 = endothelin-1

BDI = Beck Depression Inventory